Ortivus launched CoroNet in Italy and Spain

OrtivusFollowing the successful launch of CoroNet in Sweden, Ortivus now continues to build up its international sales of the system. Two of the most important markets in Europe are Italy and Spain where Ortivus now signs a partner agreement with the well-reputed and market leading company et medical devices - cardiette - CARDIOLINE.

The company, with main office in Milano, and its own subsidiaries in Spain has about 110 employees and a turnover of approximately 15 million Euro. Under the well-known brand "CARDIOLINE" et medical devices develops and promotes products such as ECG, HOLTER and STRESS-TEST solution and has a market share in Italy of approximately 40%. The company has an extensive network in Italy and Spain of cardiologists and other strategically relevant target groups for Ortivus products. In order to fully leverage on the brand recognition on the market CoroNet will be promoted under the co-brand "CARDIOLINE CoroNet".

"In et medical devices Ortivus have found a partner with a well established customer network of the kind Ortivus addresses with CoroNet. They have an organization, market presence and know-how, which fit excellent with our requirements. Furthermore, et medical's strategic decision to enlarge their portfolio with a dedicated cardiac monitoring system like CoroNet shows a top-level commitment and involvement which I believe will pay-off for both parties. We truly look forward to working together with et medical.", says Rain Eriksoo, VP Sales & Marketing at Ortivus.

"CoroNet is a strategic and hence very important addition to our overall product offering. We have scanned the market for a suitable monitoring solution to complete our portfolio and CoroNet, not only being a monitoring system but a highly innovative solution that brings an extra value to our offer and our customers is exactly what we have been looking for. With CoroNet in our portfolio we can offer our customers solutions that cover all parts of cardiology related care and improve the dissemination of our brand CARDIOLINE in the cardiology arena.", says Gian-Luca Ziliani, Marketing and Business Development Manager of et medical devices.

CoroNet is a patient monitoring system developed to specifically target hospitals and departments in the need of advanced cardiac monitoring and rehabilitation. CoroNet innovatively combines bedside and telemetry monitoring into a single seamless system. The solution has already gained a strong market share in Sweden: Karolinska in Stockholm, The University Hospital of Sahlgrenska in Gothenburg and The Academic Hospital in Uppsala are examples of prestigious hospitals that have selected Ortivus' system for their cardiology departments.

About Ortivus
Ortivus AB is a Healthcare IT company that offers information and decision-making support systems for Healthcare, Emergency Medical Services and Public Safety in Europe and North America. Ortivus AB is listed on the OMX Nordic Exchange Small Cap list and was established in 1985. Ortivus has approximately 165 employees and subsidiaries in Denmark, Germany, Great Britain, Canada, and the US. For further information please visit www.ortivus.com

About et medical Devices
et medical devices - cardiette - CARDIOLINE are highly specialized in the development, production, marketing and worldwide sales of cardiovascular technologies. The main solutions provided are integrated ECG recorders, Stress Test Systems, Holter ECG, ABPM, Defibrillators, Monitors, Rehabilitation, Selfhomecare, Telemedicine and Information Management Software. New dedicated research and development programs are progressively enlarging the products portfolio with especially patient oriented solutions. For further information please visit www.cardiette.biz www.cardioline.biz

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...